Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000

Haas, Jennifer S.; Phillips, Kathryn A.; Gerstenberger, Eric; Seger, Andrew C.

doi:10.7326/0003-4819-142-11-200506070-00006

Cited by 244 publications

(204 citation statements)

References 20 publications

Supporting

Mentioning

189

Contrasting

Unclassified

Order By: Relevance

“…However, we are not aware of prior peerreviewed reports examining the impact of Part D on generic drug use. Our findings are noteworthy given that generic drugs represent an important means of cost savings 8,9 . This is especially important given the burden of out-of-pocket costs for many Americans 26 , associations between cost sharing and non-adherence 27 , and concern about the impact of the Part D doughnut hole on processes and outcomes of care 15,28 .…”

Section: Discussionmentioning

confidence: 62%

“…Assessing the impact of Part D on generic use is important because increasing generic utilization has been considered a key policy tool to save consumers and society tens of billions of dollars 8,9 ; the average cost of generic drugs is 71% less than their brand name equivalents 10 . Although generic drug use now accounts for 63% of all US prescription drugs, considerably greater rates of generic utilization are possible.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use

et al. 2008

View full text Add to dashboard Cite

RESULTS:Generic drugs accounted for 58% of total prescriptions. Among the entire group of beneficiaries, there was a trend of increased generic drug use in 13 out of 15 drug classes examined. However, after adjusting for potential confounders, the growth rate of generic drug use was lower among Part D enrollees than among non-enrollees; enrollees were slightly less likely to fill prescriptions for generic drugs vs. brand-name drugs in 2006 compared to 2005 (odds ratio 0.95, 95% confidence interval 0.94-0.95).CONCLUSIONS: Despite secular trends of increased utilization of generic drugs among both Part D enrollees and non-enrollees, the net impact of Part D among these beneficiaries was a modest decrease in the use of generic drugs. This finding, which is consistent with economic theory but contrary to several recent reports, highlights the complexity of assessing the impact of Part D on overall consumer welfare.

show abstract

Section: Discussionmentioning

confidence: 62%

Section: Introductionmentioning

confidence: 99%

The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use

et al. 2008

View full text Add to dashboard Cite

show abstract

“…It is often easier to intervene on the expenditure of medications because their costs are easily identified. It is already proven that substitution of generic medicines can result in substantial savings [3][4][5]. As a result, the preference for promoting generic substitution among patients was reported in many countries [6,7].…”

Section: Introductionmentioning

confidence: 99%

A survey to determine the views of renal transplant patients on generic substitution in the UK

Ameri

Whittaker

Tucker

et al. 2011

Transplant International

View full text Add to dashboard Cite

Summary Rising healthcare costs promote the generic substitution among patients because it is identifiable costs. A key concern is that patients should be involved in the decision of switching. The aim of this study was to examine renal transplant patients’ views on generic substitution in the UK. A total of 163 renal patients were surveyed using 36 multiple‐choice questions at Barts and The London Renal Transplant Clinic, in the UK. Transplant recipients over 18 years, able to read and write English and willing to fill in the questionnaire were targeted; 84% of patients were conscious of the availability of generic medicines, 70% understood the terms “generic” and “branded” in relation to medicines and 54% were aware of generic substitution practice. However, 75% did not know if they were taking generics and 84% felt that generics are not equivalent or only equivalent sometimes and they were uncertain that generics had the same quality as branded medicines. Moreover, many patients admitted that they would not accept the generic substitution of ciclosporin when become available in the UK. A number of factors such as patients’ education, knowledge, severity of the disease, efficacy of generic medicines and patients’ involvement in decisions regarding their health appear to drive patients’ attitudes towards generic substitution.

show abstract

“…Along with other options, the generic substitution could be one mechanism for limiting drug expenditure by reducing prescription medicine cost (Haas et al, 2005) but it cannot guarantee the medicine price control. For example, the UK is unique in achieving a high level of generic drug use despite not employing a policy of generic substitution (King and Kanavos, 2002).…”

Section: Brand Substitutionmentioning

confidence: 99%

“…Saving by promoting and prescribing generics medicines couldn't be underestimated because of its potential effects on controlling health expenditures (Haas, 2005). For instance, in Canada the availability, prescription, dispensing and use of generic medicines approximately saved $44-billion over the past five years.…”

Section: Generic Competitionmentioning

confidence: 99%

Efficacy of international approaches to medicine price regulation and control: A scoping review

et al. 2017

View full text Add to dashboard Cite

Background:The access to affordable medicines is counted as a challenge, despite international measures taken towards cost containment and price regulation. Objective: To identify and review the literature on international approaches related to medicine price regulation, control, and its effectiveness. Methods: In this scoping review, peer-reviewed research and review articles, discussion papers, public documents relating to medicine pricing policies were reviewed. The search strategy was structured according to STARLITE principles. The key search terms and phrases were "medicine prices", "causes of high medicine prices", " approaches towards medicine prices control", "national medicine policies", "international approaches towards medicine price control", "containment policies", and "effects of pricing policy on medicine". Results: Medicine pricing and price regulation policies were drafted and implemented with no optimal results and things don't seem to have improved much and remain as the distant goal. These policies were either less comprehensive, outdated and fell short in implementation especially in low and middle-income countries (LMICs) due to lack of funding, infrastructure or trained professional task force. Overall, none of the policy options was preferred. Multi-pronged policy options crafted in local context are required to tackle the issue. Conclusion: The authors identify gaps in the literature and propose advanced research in the area to strengthen the healthcare system by improving medicine pricing system in each country.

show abstract

Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000

Abstract: Although broad substitution of generic drugs would affect only a modest percentage of drug expenditures, it could result in substantial absolute savings.

Cited by 244 publications

References 20 publications

The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use

The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use

A survey to determine the views of renal transplant patients on generic substitution in the UK

Efficacy of international approaches to medicine price regulation and control: A scoping review

Contact Info

Product

Resources

About